Use of standardised assessment forms in referrals to hepatology outpatient services: Implications for accurate triaging of patients with chronic hepatitis C

Australian Health Review

Volumn 37, Issue 2, 2013, Pages 218-222

  Horsfall, Leigh ^a   MacDonald, Graeme ^a   Scott, Ian ^a   Skoien, Richard ^b   Khatun, Mohsina ^c   Moss, Cathy ^a   Seligman, Clare ^c   Kardash, Christine ^d   Poxon, Vicki ^c   Powell, Elizabeth E ^a,c  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d University of Queensland ^*  (Australia)

Author keywords

aged referral; audit; hepatocellular cancer; long wait; service delivery.

Indexed keywords

EID: 84876018807     PISSN: 01565788     EISSN: 14498944     Source Type: Journal    
DOI: 10.1071/AH12162     Document Type: Article

References (11)

1. George J, Robotin M. Overview: hepatocellular carcinoma - the future starts now. Cancer Forum 2009;33(2)
2. Kane LJ, Macdonald GA. Risk of hepatocellular carcinoma in chronic viral hepatitis. Cancer Forum 2009;33(2)
3. Thein H, Dore GJ. Trends in chronic viral hepatitis: notifications, treatment uptake and advanced disease burden. Cancer Forum 2009; 33(2)
4. Stainkey LA, Seidl IA, Johnson AJ, Tulloch GE, Pain T. The challenge of long waiting lists: how we implemented a GP referral system for nonurgent specialist' appointments at an Australian public hospital. BMC Health Serv Res 2010; 10: 303. doi:10.1186/1472-6963-10-303
5. Queensland Health. Outpatient Services Implementation Standard. Queensland Health 2010. Available at: http://www.health.qld.gov.au/qhpolicy/ docs/imp/qh-imp-300-1.pdf.
6. Hourigan LF, Macdonald GA, Purdie D, Whitehall VH, Shorthouse C, Clouston A, et al. Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis. Hepatology 1999; 29(4): 1215-9. doi:10.1002/hep. 510290401 (Pubitemid 29168757)
7. Walsh MJ, Jonsson JR, Richardson MM, Lipka GM, Purdie DM, Clouston AD, et al. Non-response to antiviral therapy is associated with obesity and increased hepatic expression of SOCS-3 in patients with chronic hepatitis C, viral genotype 1. Gut 2006; 55(4): 529-35. doi:10.1136/gut.2005.069674
8. Rosen HR. Clinical practice. Chronic hepatitis C infection. N Engl J Med 2011; 364(25): 2429-38. doi:10.1056/NEJMcp1006613
9. Australian Government Department of Health and Aging. Third National Hepatitis C Strategy 2010-2013. Canberra: Commonwealth of Australia; 2010.
10. Roberts SK, Weltman MD, Crawford DH, McCaughan GW, Sievert W, Cheng WS, et al. Impact of high-dose peginterferon a-2A on virological response rates in patients with hepatitis C genotype 1: a randomized controlled trial. Hepatology 2009; 50(4): 1045-55. doi:10.1002/hep.23130
11. Romero-Gómez M, Del Mar Viloria M, Andrade RJ, Salmerón J, Diago M, Fernández-Rodríguez CM, et al. Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients. Gastroenterology 2005; 128(3): 636-41. doi:10.1053/j.gastro.2004.12. 049 (Pubitemid 40585366)